AHLA - Health Law Weekly Issue - March 20, 2026

March 20, 2026

Health Law Weekly

Featured Articles

Pathology Under the Microscope: Fraud and Abuse Risks and What Attorneys Need to Know

Profit or Pitfall? Legal and Compliance Risks in Emerging Health Care Revenue Models

The Governance Implications of DOJ’s New Corporate Enforcement Policy

Top Ten 2026: Medicare Advantage in Uncertain Times

Current Topics

Fraud and Compliance

Ninth Circuit Revives Whistleblower Action Against Drug Makers over Alleged 340B Drug Overcharges

Wholesale Pharmaceutical Company Owners Sentenced to Prison for Black-Market HIV Drug Distribution

Physician, Husband Sentenced for $12.5 Million Fraud Scheme

Art Therapy Company, Owner Agree to Consent Judgment Resolving FCA Allegations

OIG Allows Device Manufacturer to Subsidize Clinical Study Cost-Sharing Amounts

President Trump Signs Executive Order for Antifraud Task Force

OIG Greenlights Manufacturer’s Proposal for ASC Discounts on Cataract Surgery Supplies

OIG Approves Multi-Phase Transfer of ASC Ownership Interests for Physician’s Estate Planning

Health Law Policy and Administration Hub

First Circuit Upholds Order Blocking Federal Funding Freeze

OCR Investigating 13 States for Alleged Abortion Coverage Mandate

U.S. Court in Massachusetts Blocks HHS’ Overhaul of Childhood Immunization Schedule

U.S. Court in Illinois Enjoins HHS Public Health Funding Cuts to Four States

House Lawmakers Look to Carve Out Health Care Workers from H-1B Visa $100,000 Fee

U.S. Court in Oregon Finds HHS Declaration on Transgender Care Unlawful

Medical Staff, Credentialing, and Peer Review

Texas Appeals Court Refuses to Enjoin Hospital from Reporting Physician’s Suspension

Current Issue